Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01776827 · ClinicalTrials.gov registry record
Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital
A clinical trial of Gastroesophageal Reflux Disease and Hiatal Hernia, sponsored by University of Nebraska.
- Completed
- Registry status
- 69
- Enrollment target
- 1
- Study location
NCT01776827 is a study of Gastroesophageal Reflux Disease and Hiatal Hernia that has completed, run by University of Nebraska. The registered enrollment target is 69 participants, below the 345-participant average among 24 other Gastroesophageal Reflux Disease trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01776827, a study of Gastroesophageal Reflux Disease and Hiatal Hernia, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 69 participants
- Enrollment target
- 1
- Study location
Study Summary
To study the long term outcome of Laparoscopic Hiatal Hernia Repair with human acellular dermal matrix Alloderm (LifeCell, Branchburg, NJ) mesh.
Conditions Studied
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2012-05-22 |
| Est. Completion | 2015-02-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01776827
The ClinicalTrials.gov registry entry for NCT01776827 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 345-participant average among 24 other Gastroesophageal Reflux Disease trials with a reported enrollment target (80% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Gastroesophageal Reflux Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01776827 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT01776827 about?
NCT01776827 is a clinical study titled "Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital". To study the long term outcome of Laparoscopic Hiatal Hernia Repair with human acellular dermal matrix Alloderm (LifeCell, Branchburg, NJ) mesh.
What is the current status of trial NCT01776827?
This trial is currently completed. The enrollment target is 69 participants. The study started on 2012-05-22. Estimated completion is 2015-02-11.
What conditions does trial NCT01776827 study?
This clinical trial studies the following conditions: Gastroesophageal Reflux Disease, Hiatal Hernia, Paraesophageal Hernia.
Who is sponsoring clinical trial NCT01776827?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01776827 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroesophageal Reflux Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
-
Domperidone in Treating Patients With Gastrointestinal Disorders
RECRUITING · Phase 3
-
Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease
ACTIVE NOT RECRUITING
-
GCC Agonist Signal in the Small Intestine
ACTIVE NOT RECRUITING · Phase 1
-
Transoral Fundoplication Prior to Sleeve Gastrectomy Versus RNY Gastric Bypass on GERD Symptoms in Bariatric Patients
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.